Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification method.

Author: ByrdJohn C, ChanKenneth K, GreverMichael, LiuZhongfa, MarcucciGuido, XiaoJim

Paper Details 
Original Abstract of the Article :
Aberrant DNA methylation patterns resulting in gene transcriptional repression are observed in numerous cancers. Decitabine, a DNA methyltransferase inhibitor, is being clinically evaluated in patients with hematologic malignancies and solid tumors. Decitabine is rather unstable and decomposes to 1-...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/rcm.2423

データ提供:米国国立医学図書館(NLM)

Decitabine's Decomposition: Unveiling the Secrets of a Cancer-Fighting Drug

The field of cancer research, like a vast desert filled with hidden treasures, is constantly searching for new weapons to fight this formidable foe. This study focuses on decitabine, a drug that holds promise in the battle against various cancers, including those affecting blood and solid tissues. But decitabine, like a fragile oasis, is susceptible to decomposition, which makes it challenging to study and use effectively.

This research, like a meticulous archaeological expedition, aimed to decipher the decomposition products of decitabine, particularly its breakdown under different conditions. The researchers, like skilled explorers, used a combination of techniques to analyze the drug's decomposition, revealing hidden truths about its stability.

Understanding Decitabine: A Key to Effective Treatment

The study successfully identified the decomposition products of decitabine, revealing that it breaks down into isomers of specific compounds, like finding hidden chambers in an ancient tomb. This newfound knowledge, like a precious artifact, allows for a more precise understanding of decitabine's properties, paving the way for safer and more effective treatment strategies.

The Journey Continues: Developing Safer and More Effective Cancer Therapies

This study, like a stepping stone in a desert journey, provides valuable insights into the complex world of drug stability. By unraveling the mysteries of decitabine's decomposition, researchers are closer to developing safer and more effective treatments for cancer, like finding a path through the desert to a hidden spring of healing.

Dr. Camel's Conclusion

This research, like a journey into the heart of a desert, emphasizes the importance of understanding the intricacies of medication behavior. By unveiling the secrets of decitabine's decomposition, researchers are paving the way for more effective and targeted treatments for cancer.

Date :
  1. Date Completed 2006-05-18
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

16523529

DOI: Digital Object Identifier

10.1002/rcm.2423

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.